| Financial Year |
March 31 2023 |
| Monetary Funds |
848,373,705.85 |
| Held-for-trading Financial Assets |
149,931,055.85 |
| Notes Receivable |
86,476,005.97 |
| Accounts Receivable |
672,742,033.99 |
| Advances to Suppliers |
37,041,411.72 |
| Other Receivables |
68,517,484.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
251,272,645.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,062,477.42 |
| Total Current Assets |
2,131,416,820.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
145,577,192.42 |
| Investment Properties |
6,727,963.37 |
| Fixed Assetes |
864,192,441.45 |
| Under-construction Projects |
606,872,673.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
358,280,103.75 |
| R&D expenses |
-- |
| Goodwill |
609,879,586.35 |
| Long-Term Deferred and Prepaid Expenses |
32,315,423.21 |
| Deferred Income Tax Assets |
44,638,820.45 |
| Other Non-Current Assets |
83,301,383.17 |
| Sub-Total of Non-Current Assets |
2,776,420,526.83 |
| Total Assets |
4,907,837,347.26 |
| Short-Term Loans |
737,005,304.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
276,855,540.48 |
| Accounts Payable |
287,921,568.26 |
| Accounts Received In Advance |
18,333.34 |
| Employee Compensation Payable |
36,275,676.93 |
| Taxes Payable |
57,088,166.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
69,549,714.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,910,558.05 |
| Other Current Liabilities |
4,395,241.83 |
| Sub-Total of Current Liabilities |
1,504,746,299.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,567,320.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
60,584,091.70 |
| Total Liabilities |
1,565,330,391.08 |
| Paid-In Capital(Or Share Stock) |
621,241,828.00 |
| Capital Surplus |
1,317,978,915.16 |
| Surplus Reserve |
111,242,723.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
821,749,103.76 |
| Minority Stockholder's Interest |
440,790,257.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,901,716,699.18 |
| Owner's Equity（Stockholder's Equity） |
3,342,506,956.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,907,837,347.26 |
